← Eichor
Condition: Cervical Intraepithelial Neoplasia Grade 2 Cin2 Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Cervical Intraepithelial Neoplasia Grade 2 Cin2

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Pembrolizumab for the Treatment of Cervical Intraepithelial Neoplasia
Phase 2 · 1 location(s) · Jonsson Comprehensive Cancer Center · NCT04712851PVX4 for the Treatment of Human Papilloma Virus (HPV)16+ Cervical Dysplasia
Phase 2 · 10 location(s) · PapiVax Biotech, Inc. · NCT07454915Digital Telecytology for Triage of HPV-Positive Women in Cameroon
NA · 2 location(s) · University Hospital, Geneva · NCT07550010Evaluate the Efficacy, Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females
Phase 3 · 1 location(s) · Shanghai Bovax Biotechnology Co., Ltd. · NCT04422366Evaluation of the PreCursor-M+® in CIN2
Phase N/A · 2 location(s) · European Institute of Oncology · NCT06403618HPV DNA Vaccine Via Electroporation for HPV16 Positive Cervical Neoplasia
Phase 1 · 2 location(s) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · NCT04131413Therapeutic Abstention and Surveillance of Intra-epithelial Histological Lesions of High Grade Cervical CIN2 (Cervical I
Phase N/A · 1 location(s) · University Hospital, Bordeaux · NCT04057924Screening Study for Cervical Pre-cancer and Cancer Prevention in South African Women.
Phase N/A · 1 location(s) · University of Pretoria · NCT02956031Regression of Cervical Precancerous Lesions and Associated Risk Factors
Phase N/A · 1 location(s) · General University Hospital, Prague · NCT06147388Concomitant HPV Vaccination and HPV Screening HPV Infection and Cervical Cancer in Sweden
Phase 4 · 1 location(s) · Miriam Elfström · NCT04910802Immune Persistence After the Whole Vaccination Shcedule With Recombination Quadrivalent HPV Vaccine
Phase N/A · 2 location(s) · Shanghai Bovax Biotechnology Co., Ltd. · NCT05371353Assessment of the Effectiveness of TA Versus LEEP for Cervical Cancer Risk Reduction in WLHIV in Mozambique
NA · 1 location(s) · Instituto Nacional de Saúde, Mozambique · NCT06326294Assessing Administration of pBI-11 Via Electroporation for the Treatment of Patients With HPV16/18+
Phase 2 · 2 location(s) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · NCT06210854Urine HPV Testing for Cervical Cancer Screening Among Women Living With HIV in South Africa
NA · 1 location(s) · UNC Lineberger Comprehensive Cancer Center · NCT05413798Comparison Between Liquid-Based Cytology And Molecular Screening For Detecting Precursor Lesions and Cervical Cancer
NA · 1 location(s) · Timser SAPI de CV · NCT07480902Effect of HPV Integration on Prognosis of Young Women With CIN2 in China
Phase N/A · 20 location(s) · Fujian Maternity and Child Health Hospital · NCT05282095Predicting Response In Cervical Intraepithelial Neoplasia to Topical Imiquimod Treatment
Phase N/A · 15 location(s) · Catharina Ziekenhuis Eindhoven · NCT05405270Immunogenicity and Safety of Quadrivalent HPV Vaccine in Healthy Chinese Female Subjects Aged 9 to 19 Years
Phase 3 · 1 location(s) · Shanghai Bovax Biotechnology Co., Ltd. · NCT05027776Artesunate Vaginal Inserts for the Treatment of Cervical Intraepithelial Neoplasia (CIN2/3)
Phase 2 · 7 location(s) · Frantz Viral Therapeutics, LLC · NCT04098744Effect of Honey For CIN II
Phase 1/Phase 2 · 2 location(s) · Zuyderland Medisch Centrum · NCT06219018A Clinical Trial to Investigate the Safety and Efficacy of Papillex® on Abnormal Cervical Cells Caused by HPV.
NA · 1 location(s) · Papillex Inc. · NCT06979180
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.